No amount of creativity or product superiority will be advantageous unless the pharmaceutical company is able to get its product to the market and into the hands of the end user. It is so important to choose a top notch sales and marketing team, training them in the overall benefits and value of the products, as well as the fundamental strategies necessary to be able to achieve a desired result in the market. Sales force effectiveness is of such critical importance, yet it is often poorly reviewed or supervised. Generally, pharmaceutical consultants have the desired levels of training to be able to motivate the company sales force, resulting in considerable financial gain due to elevated efficiency.

Have you ever heard of the saying, coined by a famous football coach – “winning isn't everything, it's the only thing!” Remember to keep this mindset engaged at all times. Although valuable contacts may be made and additional experience a must, if no sales are made then no value is realised, either.

Motivation is so important and a pharmaceutical consulting firm will help create an array of appropriate measurement tools. It is important to remember that activity levels are not the “be all and end all” of sales. A sales executive is not necessarily highly efficient, even though his or her volume of sales may be high, as ultimate value must be assessed. The creation of the account must foster a value relationship between all the principals, quite apart from the raw dollar amounts involved. Of critical importance is the alignment between the company and the buyer's strategy. Sales people should not be incentivised unless there is a clear gain for the company and the client achieves value, thereby cementing the relationship.

Levels of incentive must be tied to achievable and attainable levels and goals. There must be a tangible carrot at the end of the road and achievable targets should lead to further incentives on a structured basis. If the sales executive is able to “get” to an end result, then he or she will not be adequately motivated to reach even further and keep working.

The adoption of time management cannot be underestimated and the company should strive to ensure that the sales manager is not bogged down with too many administrative elements, through the provision of the latest, cutting-edge tools to streamline work. Did you know that many sales executives actually spend less than 25% of their time in direct communication with clients?

In summary, a sales team can only be highly effective if they have been trained well and are involved in an ongoing process of training. Such training will include education in the products to be sold, latest sales techniques and delivery processes in addition to management of time and the vital elements of interpersonal communication. To help get this right, engage pharma consulting experts.

Alan Gillies is the Director of L2L Consulting, an elite pharmaceutical consultancy firm which specialises in Strategy Development and Implementation Excellence for prestigious multi-national organisations.

Some business practitioners use a metric termed the 80/20 rule, which dictates that 80% of an organisation's business comes from just 20% of its clients. Whether this is essentially correct or not, it is certainly true that some clients take on additional importance in the eyes of the pharmaceutical company, whether this is from the point of view of transactions, their market dominance or other more strategic elements such as the provision of a gateway to other segments and markets. Key account management provisions should be brought in by the company and all members of the sales and marketing team made keenly aware of their existence and importance.

A pharmaceutical company has many different stakeholders and must satisfy a number of different “clients.” So many different issues have to be addressed including the company's position, public relations and media activities, lobbying in political circles, quite apart from core issues of marketing and economics. There is a lot to take on, from a daily and weekly perspective and company executives must ensure that they do not try and address too many complex issues while diluting their overall effectiveness. Key account management will not be effective if certain layers of communication are not maintained, leading to a less efficient sales and marketing operation and calling for a pharmaceutical consulting firm to be retained for best effect.

Following the appointment of a specific account to the role of “key,” the pharmaceutical consultants should help in composing a concerted plan of action. The business must look at the relationship from the client point of view and accurately gauge what they feel to be the substance of the relationship. There should be an interactive approach to communication here and the goal should be to create a “win-win” scenario at all times, regardless of complexity. The key account is more likely to want to continue with the company if value is delivered over and above the core essentials.

A comfort zone must be the desired result, for if the client senses this, then a continuation can be expected and an expansion possible. When trust is established, the client will often not have to engage so many of its resources in trying to oversee and control the related activities and will foresee the relationship as an efficient one.

It has been said that account management is often one of “damage control.” Certainly issues and problems will arise from time to time. It falls to the company to try and understand how a client works and to do its best to anticipate any problems or objections before they occur. If a sales and marketing team has achieved a high level of training and education, it will be much better positioned to get past the hurdles in its path.

Key account management requires a constant review of the client's interpretation of the relationship. Satisfaction is paramount and should the company and its executives go the extra distance, an enhanced relationship and additional revenue opportunities are very likely. In almost every instance, pharma consulting firms practice the art of delivering satisfaction.

Alan Gillies is the CEO of L2L Consulting, a cutting-edge pharma consultancy firm which specialises in optimising productivity and performance within international companies by applying tailored organisational strategies.